Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass?

[1]  T. Walle,et al.  Aromatase inhibition by bioavailable methylated flavones , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[2]  J. Koropatnick,et al.  Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. , 2007, Cancer letters.

[3]  T. Walle,et al.  Novel methoxylated flavone inhibitors of cytochrome P450 1B1 in SCC‐9 human oral cancer cells , 2007, The Journal of pharmacy and pharmacology.

[4]  T. Walle,et al.  Cancer chemopreventive properties of orally bioavailable flavonoids--methylated versus unmethylated flavones. , 2007, Biochemical pharmacology.

[5]  Takuji Tanaka,et al.  Protective effects of citrus nobiletin and auraptene in transgenic rats developing adenocarcinoma of the prostate (TRAP) and human prostate carcinoma cells , 2007, Cancer science.

[6]  Hui Wang,et al.  Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway. , 2007, Cancer research.

[7]  T. Walle,et al.  Cytochrome P450 1B1, a novel chemopreventive target for benzo[a]pyrene-initiated human esophageal cancer. , 2007, Cancer letters.

[8]  Jen-kun Lin,et al.  Tangeretin suppresses IL-1beta-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells. , 2007, Biochemical pharmacology.

[9]  T. Walle,et al.  Accumulation and metabolism of the anticancer flavonoid 5,7-dimethoxyflavone compared to its unmethylated analog chrysin in the Atlantic killifish. , 2006, Chemico-biological interactions.

[10]  Myung-Suk Kim,et al.  Curcumin Inhibits Hypoxia-Inducible Factor-1 by Degrading Aryl Hydrocarbon Receptor Nuclear Translocator: A Mechanism of Tumor Growth Inhibition , 2006, Molecular Pharmacology.

[11]  T. Walle,et al.  Methylated Flavonoids Have Greatly Improved Intestinal Absorption and Metabolic Stability , 2006, Drug Metabolism and Disposition.

[12]  B. Rosner,et al.  Prospective study of fruits and vegetables and risk of oral premalignant lesions in men. , 2006, American journal of epidemiology.

[13]  Weiya Ma,et al.  (-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78. , 2006, Cancer research.

[14]  M. Kano,et al.  Bioavailability of isoflavones after ingestion of soy beverages in healthy adults. , 2006, The Journal of nutrition.

[15]  P. Harper,et al.  Regulating the regulator: factors that control levels and activity of the aryl hydrocarbon receptor. , 2006, Biochemical pharmacology.

[16]  D. Wei,et al.  Citrus Flavonoids in Fruit and Traditional Chinese Medicinal Food Ingredients in China , 2006, Plant foods for human nutrition.

[17]  L. Chiang,et al.  Anti-proliferative effect of apigenin and its apoptotic induction in human Hep G2 cells. , 2006, Cancer letters.

[18]  B. Zhivotovsky,et al.  Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity. , 2006, Cancer research.

[19]  T. Walle,et al.  Methylation protects dietary flavonoids from rapid hepatic metabolism , 2006, Xenobiotica; the fate of foreign compounds in biological systems.

[20]  H. Ohta,et al.  Flavonoid Composition of Fruit Tissues of Citrus Species , 2006, Bioscience, biotechnology, and biochemistry.

[21]  T. Walle,et al.  Inhibition of benzo[a]pyrene-activating enzymes and DNA binding in human bronchial epithelial BEAS-2B cells by methoxylated flavonoids. , 2005, Carcinogenesis.

[22]  T. Adrian,et al.  Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest , 2006, Molecular Cancer.

[23]  M. Haghiac,et al.  Quercetin Induces Necrosis and Apoptosis in SCC-9 Oral Cancer Cells , 2005, Nutrition and cancer.

[24]  T. Walle,et al.  Preferential induction of CYP1B1 by benzo[a]pyrene in human oral epithelial cells: impact on DNA adduct formation and prevention by polyphenols. , 2005, Carcinogenesis.

[25]  Hui You,et al.  Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells. , 2005, Cancer research.

[26]  K. Bock,et al.  Ah receptor- and TCDD-mediated liver tumor promotion: clonal selection and expansion of cells evading growth arrest and apoptosis. , 2005, Biochemical pharmacology.

[27]  T. Gasiewicz,et al.  Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein. , 2005, Biochemistry.

[28]  T. Walle,et al.  5,7-Dimethoxyflavone downregulates CYP1A1 expression and benzo[a]pyrene-induced DNA binding in Hep G2 cells. , 2005, Carcinogenesis.

[29]  G. Leclercq,et al.  Tangeretin inhibits extracellular‐signal‐regulated kinase (ERK) phosphorylation , 2005, FEBS letters.

[30]  Bing-Hua Jiang,et al.  Apigenin inhibits VEGF and HIF‐1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  A. Murakami,et al.  Nobiletin, a Citrus Flavonoid, Down-Regulates Matrix Metalloproteinase-7 (matrilysin) Expression in HT-29 Human Colorectal Cancer Cells , 2005, Bioscience, biotechnology, and biochemistry.

[32]  J. Liao,et al.  Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. , 2005, The American journal of clinical nutrition.

[33]  T. Walle,et al.  HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS , 2004, Drug Metabolism and Disposition.

[34]  J. Donovan,et al.  Pharmacokinetics and metabolism of dietary flavonoids in humans. , 2004, Free radical research.

[35]  J. Manthey,et al.  Hypolipidemic effects and absorption of citrus polymethoxylated flavones in hamsters with diet-induced hypercholesterolemia. , 2004, Journal of agricultural and food chemistry.

[36]  C. Rice-Evans,et al.  Flavonoids: antioxidants or signalling molecules? , 2004, Free radical biology & medicine.

[37]  A. Dennison,et al.  Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration , 2004, British Journal of Cancer.

[38]  C. Elferink,et al.  Cytochrome P4501A1 promotes G1 phase cell cycle progression by controlling aryl hydrocarbon receptor activity. , 2004, Molecular pharmacology.

[39]  P. Kittakoop,et al.  Bioactive flavonoids from Kaempferia parviflora. , 2003, Fitoterapia.

[40]  A. Gurevich,et al.  Flavonoid components of propolis , 1969, Chemistry of Natural Compounds.

[41]  S. Safe,et al.  Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context. , 2003, Environmental health perspectives.

[42]  S. Pervaiz.  Resveratrol: from grapevines to mammalian biology , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  D. Goldberg,et al.  Absorption of three wine-related polyphenols in three different matrices by healthy subjects. , 2003, Clinical biochemistry.

[44]  Jen-kun Lin,et al.  Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. , 2002, Carcinogenesis.

[45]  J. Manthey,et al.  Antiproliferative activities of citrus flavonoids against six human cancer cell lines. , 2002, Journal of agricultural and food chemistry.

[46]  Stephen S Hecht,et al.  Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. , 2002, The Lancet. Oncology.

[47]  T. Walle,et al.  Glucuronidation versus oxidation of the flavonoid galangin by human liver microsomes and hepatocytes. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[48]  Takashi Sato,et al.  Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and -9 in human fibrosarcoma , 2002, Cancer research.

[49]  A. Murakami,et al.  Characteristic rat tissue accumulation of nobiletin, a chemopreventive polymethoxyflavonoid, in comparison with luteolin , 2002, BioFactors.

[50]  C. Pouget,et al.  Flavonoids: structural requirements for antiproliferative activity on breast cancer cells. , 2001, Bioorganic & medicinal chemistry letters.

[51]  Y. Okada,et al.  The Citrus Flavonoid, Nobiletin, Inhibits Peritoneal Dissemination of Human Gastric Carcinoma in SCID Mice , 2001, Japanese journal of cancer research : Gann.

[52]  Y. Ju,et al.  Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. , 2001, The Journal of nutrition.

[53]  S. Safe,et al.  Involvement of a post-transcriptional mechanism in the inhibition of CYP1A1 expression by resveratrol in breast cancer cells. , 2001, Biochemical pharmacology.

[54]  G. Beecher,et al.  Catechins are bioavailable in men and women drinking black tea throughout the day. , 2001, The Journal of nutrition.

[55]  P. Halushka,et al.  Disposition and metabolism of the flavonoid chrysin in normal volunteers. , 2001, British journal of clinical pharmacology.

[56]  K. Grohmann,et al.  Biological properties of citrus flavonoids pertaining to cancer and inflammation. , 2001, Current medicinal chemistry.

[57]  S. Prabhu,et al.  Prevention of carcinogenesis by tea polyphenols*† , 2001, Drug metabolism reviews.

[58]  D. Alberts,et al.  Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[59]  S. Safe,et al.  3',4'-dimethoxyflavone as an aryl hydrocarbon receptor antagonist in human breast cancer cells. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[60]  E. Middleton,et al.  The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. , 2000, Pharmacological reviews.

[61]  A. Murakami,et al.  Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. , 2000, Cancer research.

[62]  M. Kikuchi,et al.  Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. , 2000, The Journal of nutrition.

[63]  A. Thomaïdis,et al.  Apigenin inhibits endothelial‐cell proliferation in G2/M phase whereas it stimulates smooth‐muscle cells by inhibiting P21 and P27 expression , 2000, International journal of cancer.

[64]  H. Ciolino,et al.  Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. , 1999, Molecular pharmacology.

[65]  T. Walle,et al.  Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2. , 1999, Biochemical pharmacology.

[66]  H. Ciolino,et al.  Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. , 1999, The Biochemical journal.

[67]  H. Ciolino,et al.  Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. , 1998, Biochemical pharmacology.

[68]  C. Laughton,et al.  Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study. , 1998, Environmental health perspectives.

[69]  R. Read,et al.  Constituents of the leaves of Piper caninum. , 1997, Planta medica.

[70]  L. Santos,et al.  Constituents from the leaves of Virola michelli , 1996 .

[71]  T. Hirano,et al.  Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. , 1995, British Journal of Cancer.

[72]  Toshiyuki,et al.  Chemotaxonomy of the Genus Citrus Based on Polymethoxyflavones. , 1991 .

[73]  P. Artursson,et al.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.

[74]  P. Artursson.  Cell cultures as models for drug absorption across the intestinal mucosa. , 1991, Critical reviews in therapeutic drug carrier systems.

[75]  C. Harris,et al.  Establishment and characterization of SV40 T-antigen immortalized human esophageal epithelial cells. , 1991, Cancer research.

[76]  C. Harris,et al.  Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. , 1988, Cancer research.

[77]  Massayoshi Yoshida,et al.  Lignoids from the fruit of three Virola species , 1985 .

[78]  V. Reutrakul,et al.  Flavonoids in the black rhizomes of Boesenbergia panduta , 1983 .